🤔 Curious about the latest insights from the CPHI community and the pharmaceutical industry? The CPHI Customer Insights Team is your go-to source! ✅ All you need is to complete the survey, and we’ll ensure you receive an exclusive infographic packed with must-know insights about the CPHI Community, just in time for CPHI Milan 2024! Don't miss out on staying ahead in the industry – click the link to participate now: https://ow.ly/fvno50SvNex 🎁 Plus you will have a chance to win one of the five €100 vouchers! #CPHIFeedback #survey #AtTheHeartOfPharma #pharma #biopharma
CPHI’s Post
More Relevant Posts
-
🖋️ Emerging Tech Ghostwriter | 🧰 Full-Stack Marketer | 🧪 DeSci Evangelist | Elevating Biotech, Healthcare, DeSci, and Blockchain Startups Through Premium Content Services
Federated data networks and federated learning are going to unlock massive amounts of innovation in the coming years, especially for heavily regulated and secure industries like healthcare. When you can fully unlock the potential of data by breaking down siloes and increasing collaboration, the possibilities are endless. Great work from the team at Lifebit! #machinelearning #federatedlearning #ai #biotech #healthtech
Thank you, Outsourcing-Pharma for sharing our recent news! https://bit.ly/3P1KwuW Our company has achieved an incredible feat: unlocking the potential of diverse data to accelerate pharmaceutical research and development. We've reached a pivotal moment by cataloguing data from over 100 million patients in our multi-omic and health data repository 👩💻 This milestone represents a significant advancement in pharmaceutical research and development capabilities, made possible through our innovative federated data partnerships. 🤝 In case you haven't read it already, you can find more details about our extensive data catalog here: https://bit.ly/49Sq3AB
-
Counting down the days until the Pharmaceutical Management Science Association (PMSA) annual Conference 2024! Join our speakers Nitin Raizada and Maria Robles as they dive into the latest GenAI trend shaping the pharma industry. #FutureReadyHealthcare
-
-
📍 Something to share with the #CGT community - and the #analytical experts out there. This reminds me in something I often experience: Coriolis Pharma is well known for formulation development, but sometimes my contacts are surprised that we are also doing ALL the analysis in-house. Yes, in-house! 🎆 👩🔬 So this is also a reminder for you: Coriolis is your analytical expert! 👨🔬 💡 Stay tuned for more, as we are also expanding our analytical services portfolio continuously under #GMP.
Do you work with #lentiviruses? Then you will certainly be interested in our latest publication entitled "Challenges in the analysis of pharmaceutical lentiviral vector products by orthogonal and complementary physical (nano)particle characterization techniques". 💡 The publication is the result of our long-term collaboration with The Janssen Pharmaceutical Companies of Johnson & Johnson and is freely available until July 27! 👉 https://lnkd.in/dd2ZmS5s Many thanks to all authors and co-authors: Daniela Stadler, Constanze H., Klaus Wuchner, Jürgen Frank, Klaus Richter, Andrea Hawe and Tim Menzen. #CoriolisPharma #lvv #publication #sciencematters
-
-
"If you gave the same molecule to two different #biopharma companies in Phase 1, would they be equally successful?" The short answer is "no", so the more interesting question is what makes the difference... Mike Rea and I will unpack this question by discussing key industry insights on #pharmaceuticalinnovation and invention from IDEA Pharma | From R&D to RxD's 2024 Pharmaceutical Innovation & Invention Index. You can join this free webinar or receive the recording here: https://lnkd.in/e98kiGpD
Webinar Alert 📢 On the 18th of June we are hosting a 'Deep Dive' webinar - summarising the 2024 Pharmaceutical Innovation & Invention Index results and picking through some of the main themes that shape the latest ranking. https://lnkd.in/e4wfVmkF Free to join, sign up to listen live or receive the recordings to your inbox 📩 with Mike Rea & Jacqueline Barendregt from IDEA Pharma | From R&D to RxD 👏 18th June 2024 10:00 AM EST 3:00 PM BST 4:00 PM CET
-
-
The rise of private-label pharmaceutical distributors is changing biosimilar adoption and making contracting more complex. https://ow.ly/IiBO50T1zVh MMIT’s Benjamin Hinton II, PharmD, RPh, discusses the influence of major payers/PBMs and the loss of interchangeability as a differentiator in Drug Channels Institute, an HMP Global Company. Click the link in this post to read the article. #PharmacyBenefitManagers #BiosimilarManufacturers #MarketAccess
-
-
Check out this interview and article from industry experts Diluks De Silva and Geoff Micks at PMWS 2023 about talent acquisition in the pharmaceutical industry! 🌟 Stay ahead with the latest insights and strategies. https://lnkd.in/eYU88HUb #PharmaTalent #InnovativeRecruitment #PMWS2023 🏥💼
-
-
At Elma Research, we have learned to harness the value of European Medicines Agency (EMA) recognised Patient Experts and have been increasingly leveraging these important stakeholders in our research. Join us for this free webinar with Niall Baker, Director, Elma Research and Paola Kruger, European Medicines Agency (EMA) Patient Expert, where they will outline the key benefits of working with patient experts in pharmaceutical market research studies. To register, please follow this link: https://lnkd.in/efyrXywW #elmaresearch #leadingwithideas #marketresearch #Insight #mrx #PatientExpert #EMA
-
-
Tomorrow is the #modularcontent webinar. Very recommended for all that focus on #personaization and content automation.
CTO at Viseven, Creator of eWizard - Revolutionizing Digital Marketing in Healthcare | I provide digital and automation solutions for pharma
Last call to join us for a webinar on modular content! Hosted by Anna Malivska, Product Manager at eWizard, this event promises to deliver valuable insights from years of working with modular content in the pharmaceutical industry. Register here: https://lnkd.in/euSJV8P8 #modularcontent
-
-
The pharmaceutical landscape is witnessing a significant shift! GLP-1 medications, such as Eli Lilly’s Mounjaro and Novo Nordisk’s Ozempic, are set to become the top-selling drug class of 2024, overtaking PD-1 inhibitors. With projected sales nearing $50 billion, GLP-1s are rapidly becoming the cornerstone of treatments for metabolic disorders and beyond. Laxxon Medical is joining the weight loss drug development initiative with an oral GLP-1 Agonist treatment, LXM.2. You can learn more about our GLP-1 project, LXM.2, here: https://lnkd.in/dDT93dca Explore the dynamics fueling the weight loss market growth and what it means for the future of medical treatments: https://lnkd.in/gHgNdEMJ #pharmaceutical #3dprinting #medicalinnovation #medicaltechnology #SPID #LaxxonMedical #3DSP #InnovateWithUs
-
-
>NEXT Live 24' Dubrovnik - 🌟 Speaker Announcement 🎤> Meet Kate Bradford from Alexion Pharmaceuticals, Inc. as one of our brilliant speakers at NEXT Pharma Summit 24' in Dubrovnik. 🎉 If you are keen to learn what's NEXT for pharma, save the date - May 14&15 2024! Learn more here - https://lnkd.in/dHygj3Zh #digitaltransformation #nextpharmasummit #pharmamarketing #medicalaffairs #pharma #pharmaceuticals
-
